Biogen/ US09062X1037 /
6/17/2025 3:51:50 PM | Chg. -1.34 | Volume | Bid3:52:20 PM | Ask3:52:20 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
129.72USD | -1.02% | 1,976 Turnover: 256,822.17 |
129.53Bid Size: 120 | 175.00Ask Size: 315 | 19.07 bill.USD | - | 11.61 |
GlobeNewswire
6/16
Supernus Pharmaceuticals to Acquire Sage Therapeutics, Strengthening its Neuropsychiatry Product Por...
GlobeNewswire
6/12
Dapirolizumab Pegol Phase 3 Data in SLE Presented at the Annual European Congress of Rheumatology (E...
GlobeNewswire
6/9
Lyell Immunopharma Strengthens Clinical and Commercial Capabilities with Key Board and Executive App...
GlobeNewswire
6/5
Kailera Therapeutics Appoints Adam Koppel and Christopher Hite to Board of Directors
GlobeNewswire
5/29
Vima Therapeutics Launches to Advance the First Oral Therapy for People with Dystonia and Related Mo...
GlobeNewswire
5/27
Biogen and City Therapeutics Announce Strategic Research Collaboration to Develop Select Novel RNAi-...
GlobeNewswire
5/21
Coave Therapeutics Establishes New Scientific Advisory Board to Accelerate Innovation in Genetic Med...
GlobeNewswire
5/14
Inozyme Pharma Reports First Quarter 2025 Financial Results and Provides Business Highlights
GlobeNewswire
5/14
Yaqrit strengthens funding and regulatory capability ahead of clinical trials with board and senior ...
GlobeNewswire
5/13
Algernon to Acquire NoBrainer Imaging Centers, Inc. - Plans to Establish Alzheimer’s Diagnostic and ...
GlobeNewswire
5/12
PRISM MarketView Honors Mental Health Awareness Month with a Spotlight on Emerging Innovators
GlobeNewswire
5/12
Jeito Capital Strengthens Leadership for Next Chapter of Growth: Mehdi Ainouche Promoted to Partner,...
GlobeNewswire
5/6
Denali Therapeutics Reports First Quarter 2025 Financial Results and Business Highlights Including C...
GlobeNewswire
4/23
Anavex Life Sciences Announces Appointment of Dr. Audrey Gabelle, MD, PhD to the Scientific Advisory...